About Enhancer

Enhancer ID: E_01_0667
Species: human
Position : chr7:148804374-148806374
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Lung adenocarcinoma
Pubmed ID:  30343006
Enhancer experiment: Immunohistochemical Analyses
Enhancer experiment description: EZH2-expressing lung adenocarcinomas were shown to express the PD-L1 protein more frequentlym than were nonexpressing lesions. This study provides the first evidence of a possible association between the EZH2 and PD-L1 expression in patients with resected lung adenocarcinoma.

About Target gene

Target gene : --
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: EZH2-expressing lung adenocarcinomas were shown to express the PD-L1 protein more frequentlym than were nonexpressing lesions. This study provides the first evidence of a possible association between the EZH2 and PD-L1 expression in patients with resected lung adenocarcinoma.

About TF

TF name : EZH2(ENX-1,ENX1b,KMT6,KMT6A,WVS,WVS2,EZH2)
TF experiment: Immunohistochemical Analyses
TF experiment description: EZH2-expressing lung adenocarcinomas were shown to express the PD-L1 protein more frequentlym than were nonexpressing lesions. This study provides the first evidence of a possible association between the EZH2 and PD-L1 expression in patients with resected lung adenocarcinoma.

About Function

Enhancer function : EZH2-expressing lung adenocarcinomas were shown to express the PD-L1 protein more frequentlym than were nonexpressing lesions. This study provides the first evidence of a possible association between the EZH2 and PD-L1 expression in patients with resected lung adenocarcinoma.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
EZH2-expressing lung adenocarcinomas were shown to express the PD-L1 protein more frequentlym than were nonexpressing lesions. This study provides the first evidence of a possible association between the EZH2 and PD-L1 expression in patients with resected lung adenocarcinoma.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number
EZH2 Activation of anterior HOX genes in hindbrain development during early embryogenesis reactome 120
EZH2 Oxidative Stress Induced Senescence reactome 120
EZH2 PKMTs methylate histone lysines reactome 64
EZH2 PRC2 methylates histones and DNA reactome 71
EZH2 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
EZH2 Hs_Interactome_of_polycomb_repressive_complex_2_(PRC2)_WP2916_88672 wikipathways 15

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs